| Literature DB >> 34945354 |
Muthu Thiruvengadam1, Govindasamy Rajakumar2, Venkata Swetha3, Mohammad Azam Ansari4, Saad Alghamdi5, Mazen Almehmadi6, Mustafa Halawi7, Lakshmanan Kungumadevi8, Vaishnavi Raja8, Sulthana Sabura Sarbudeen8, Saranya Madhavan9, Maksim Rebezov10,11, Mohammad Ali Shariati10, Alexandr Sviderskiy12, Konstantin Bogonosov10.
Abstract
Nanotechnology has undergone significant development in recent years, particularly in the fabrication of sensors with a wide range of applications. The backbone of nanotechnology is nanostructures, which are determined on a nanoscale. Nanoparticles are abundant throughout the universe and are thought to be essential building components in the process of planet creation. Nanotechnology is generally concerned with structures that are between 1 and 100 nm in at least one dimension and involves the production of materials or electronics that are that small. Carbon nanotubes (CNTs) are carbon-based nanomaterials that have the structure of tubes. Carbon nanotubes are often referred to as the kings of nanomaterials. The diameter of carbon is determined in nanometers. They are formed from graphite sheets and are available in a variety of colors. Carbon nanotubes have a number of characteristics, including high flexibility, good thermal conductivity, low density, and chemical stability. Carbon nanotubes have played an important part in nanotechnology, semiconductors, optical and other branches of materials engineering owing to their remarkable features. Several of the applications addressed in this review have already been developed and used to benefit people worldwide. CNTs have been discussed in several domains, including industry, construction, adsorption, sensors, silicon chips, water purifiers, and biomedical uses, to show many treatments such as injecting CNTs into kidney cancers in rats, drug delivery, and directing a near-infrared laser at the cancers. With the orderly development of research in this field, additional therapeutic modalities will be identified, mainly for dispersion and densification techniques and targeted drug delivery systems for managing and curing posterior cortical atrophy. This review discusses the characteristics of carbon nanotubes as well as therapeutic applications such as medical diagnostics and drug delivery.Entities:
Keywords: applications; carbon nanotubes; methodologies; nanomaterials
Year: 2021 PMID: 34945354 PMCID: PMC8708822 DOI: 10.3390/mi12121502
Source DB: PubMed Journal: Micromachines (Basel) ISSN: 2072-666X Impact factor: 2.891
Figure 1An overview of properties of CNTs and with synthetic and transdermal applications.
Figure 2Schematic representation of decorating multiwalled carbon nanotubes with cadmium sulfide nanoparticles using in situ polymerized PTh serving as an inter-linker. (Reprinted with permission from [28]. Copyright 2010, Feng et al.).
Figure 3Detection of Nanotube Bioconjugates in Tumors in vivo. Representative frames from time-lapse videos acquired by 3-color, intravital two-photon microscopy (a–c). Mice bearing the HN12 xenografts were anesthetized and treated with SQ or SQE (red) bioconjugates. Cell nuclei were stained with Höechst (blue) and blood vessels with 500 kDa FITC-dextran (green): For SQ alone with no EGF (a), very little or no red fluorescence representing the Qdot signal was detected within the tumor mass 45 min after injection. Two different views after administration of SQE giving red fluorescence 45 min post injection within the tumor microenvironment (b,c). The red SQE bioconjugate is localized in close proximity to the nuclei suggesting its internalization by the tumor cells within the xenograft. (Scale bar in a-c is 20 µm). Confocal microscopy images of fixed xenograft cryosections (d–f) In the SQ treated tumor sections (d), only Höechst stained cell nuclei (blue) and vascular FITC-labeled dextran (green) are visible (scale bar 30 µm). (e) In SQE treated mice, characteristic red fluorescence was widely distribution within the tumor microenvironment. (scale bar 50 µm). (f) Magnified dotted region of (e) showing internalized SEQ bioconjugates the cells within the tumor mass. (scale bar 10 µm). (Reprinted with permission from [59]. Copyright 2009, Bhired et al.) (a–f).
Figure 4In vitro examination of the relationships between lysosomal and mitochondrial damage. (A) Effects of SWCNTs on the production of reactive oxygen species (ROS) in lysosomes. (B) Effects of SWCNTs on the production of ROS in mitochondria. NAC, N-acetylcysteine (10 μmol L−1); Vit E, vitamin E (10 μmol L−1). *** p < 0.001 compared with control. &&& p < 0.001 compared with SWCNT. && p < 0.01 compared with SWCNT. (C) The influence of mitochondria on the lysosomal damage by SWCNTs. Mitochondria were added at the indicated concentrations, and the activities of β-galactosidase were measured. Lysosomal damage was expressed as the activity of the β-galactosidase leaked from lysosomes. *** p < 0.001 compared with control. (D) Fluorescence images showing the influences of SWCNTs on the mitochondrial membrane potential (MMP). Green fluorescence increased and red fluorescence decreased with incubation time. (E) Changes in the red-to-green fluorescence ratios in the mitochondrial membranes over 25 min of incubation with SWCNTs. SWCNTs significantly decreased the ratio time-dependently. (F) The time courses for the changes of both MMP and mitochondrial ROS production. (Reprinted with permission from [77]. Copyright 2010, Yang et al.).
Figure 5The drug delivery procedure is depicted graphically. (a) The surface of the carbon nanotube is linked to a chemical receptor and drugs are loaded inside, (b) the open end of the carbon nanotube is capped, (c) the drug-carbon nanotubes carrier is introduced into the body and reaches target cells via the chemical receptor on the carbon nanotubes surface, (d) the cell internalizes the carbon nanotubes via the endocytosis pathway, for example, (e,f) the cap is removed or biodegrades inside the cell, and then drugs are released.